GSK is set to announce US job cuts this week, sales reps are getting the axe in China, and the FDA has rejected Avanir’s inhalable migraine medication.
Salix-Cosmo tax-inversion deal quashed, chronic heart failure market set to expand, rising generic drug prices get lawmakers’ attention, NICE gives leukemia drug a thumbs-down, FDA has a good rep
Five things for Pharma Marketers to know: Monday, September 29